Amicus Therapeutics (FOLD)

4.89 -0.10  -2.00%  May 29, 11:52AM Go Pro
Watch this stock

Amicus Therapeutics R&D Expense: 14.00M

Get Interactive Chart for


of


Select a metric
 
Date range: to
<Embed Chart> Pro Save as Image Pro Data Export
Attention OK

FOLD R&D Expense Rankings

Overall 27th percentile 1283 of 1763
Sector 26th percentile 302 of 413 in Healthcare
Industry 29th percentile 107 of 151 in Biotechnology

FOLD R&D Expense Range, Past 5 Years

Minimum 6.783M Jun 2007
Maximum 14.40M Dec 2011
Average 10.69M

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

FOLD News

$FOLD http://stks.co/40of
about 2 hours ago by Engi
10 biotech securities will be added to the Nasdaq biotech index on May 21: $CERS $CLDX $FOLD $INFI $JAZZ $OMER $OREX $PCRX $RPTP $TSRX
about 14 days ago by abubnic
Listen to $FOLD Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3mFn
about 19 days ago by earningscast
$FOLD http://stks.co/3Tqh
about 35 days ago by Engi
$FOLD http://stks.co/3Lqx Long setup. Bullish engulfing. 200MA support.
about 44 days ago by VexTrades
$FOLD--Some huge insider buys just came through at 5.70. Do your own research. This looks like a stock offering, but insiders are buying.
about 81 days ago by MicroInsider
$FOLD forms bearish &quot;Head and Shoulders Top&quot; chart pattern. http://stks.co/2hZy
about 83 days ago by RecogniaEvents
$ECTE i see great potential in this one. A skin glucose monitor with no sticks!! Also long $FOLD for a long term play...
about 87 days ago by Stuckinstock
$FOLD Announces Proposed Public Offering of Common Stock; No Amount Given
about 89 days ago by Benzinga
Listen to $FOLD Q4 2011 earnings call (EPS -0.25 vs est -0.37) - live at 05:00 PM, ondemand after - http://stks.co/2Nmy
about 106 days ago by earningscast
$fold,,double bottom 6.93
about 106 days ago by teevee
10:50EST $FOLD Up 8% for the day. Reporting Earnings Today. http://stks.co/2NKe #tradeideas #stocks #investing #earnings
about 106 days ago by TradeIdeas1
$FOLD Presents Preclinical Studies for Gaucher Disease; AVI BioPharma Results From Phase I Clinical Trial. http://stks.co/2LHx
about 109 days ago by abubnic
$FOLD hod on deck
about 133 days ago by tradueruski
$FOLD hod pop
about 133 days ago by tradueruski
$FOLD filed latest Quarterly Report http://stks.co/vVr
about 209 days ago by MarketBrief
$FOLD filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/nqC
about 216 days ago by MarketBrief
$FOLD http://chart.ly/o5dekj2 long setup
about 274 days ago by stt2318
$FOLD $6.01 Crowley John F director officer (Executive Chairman) P 20,000 @ $6.04 amnt $120,800 proc&#39;d ($600) 6/17/2011
about 343 days ago by canarionyc
$FOLD $7.56 Valenzano Ken officer (VP, Pharmacology &amp; Biology) S 2,250 @ $7.50 amnt $16,875 proc&#39;d ($135) 5/24/2011
about 370 days ago by canarionyc
$FOLD $30m shelf, max px $4.33
about 504 days ago by canarionyc
Register for BioNJ's annual meeting held 1/27/11, featured speaker J. Crowley, Amicus $FOLD CEO. Register at http://bit.ly/hxEerO #BioNJADM
about 515 days ago by MDBpartners
Best Stock List recommended $FOLD -Amicus Therapeutics, Inc. on 10/25/2010 16:00:00 and has gained 4.13%! $SPY http://bit.ly/gvoEjM
about 516 days ago by Tieler
Best Stock List recommended $FOLD -Amicus Therapeutics, Inc. on 10/25/2010 16:00:00 and has gained 4.13%! $SPY http://bit.ly/hLiIKn
about 516 days ago by Tieler
Hey. How about my $FOLD call last week? It&#39;s going higher. If not now, for the January Effect
about 890 days ago by TheNewHouse
$FOLD should be on all January Effect players lists. Tax loss selling of the previous year&#39;s IPOs often rebound in the new year.
about 893 days ago by TheNewHouse
NASDAQ 3 biggest decliners: $FOLD -34.59%, $FPBI -30.86%, $SNFCA -22.11%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 966 days ago by datajunkies
NASDAQ 3 biggest decliners: $DEER -46.44%, $FOLD -34.59%, $FPBI -30.86%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 966 days ago by datajunkies
NASDAQ 3 biggest decliners: $DEER -46.44%, $FOLD -34.59%, $FPBI -30.86%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 967 days ago by datajunkies
NASDAQ 3 biggest decliners: $DEER -46.71%, $FOLD -33.29%, $FPBI -23.44%, Fueled by NASDAQ Last Sale http://bit.ly/datajunkies
about 967 days ago by datajunkies
Yup, $FOLD failed PII Gaucher study. Good news for $PLX &amp; $GENZ (assuming $GENZ ever gets thteir plan opened).
about 970 days ago by delete
Uh oh two halts in biotechs $FOLD and $SCLN. Friday night AH halt is usually not a good sign.
about 970 days ago by delete

Recent Quotes

Symbol Price Chg Chg % Market Cap
FOLD 4.89 -0.10 -2.00% 222.80M
FOH 0.37 +0.00 +0.00% 14.40M
FOF 12.20 +0.11 +0.91%
FOE 4.62 +0.04 +0.87% 396.49M
FNSR 15.11 +0.52 +3.56% 1.325B
FLY 12.35 +0.03 +0.24% 316.01M
FLXS 20.04 +0.05 +0.25% 135.13M
FLT 38.37 -0.09 -0.23% 3.181B
FLR 50.48 +0.78 +1.57% 8.422B
FLOW 3.04 -0.03 -0.98% 146.93M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close